These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1491329)

  • 1. In vitro release of nitroglycerin from topical products by use of artificial membranes.
    Wu ST; Shiu GK; Simmons JE; Bronaugh RL; Skelly JP
    J Pharm Sci; 1992 Dec; 81(12):1153-6. PubMed ID: 1491329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microencapsulation of citronella oil for mosquito-repellent application: formulation and in vitro permeation studies.
    Solomon B; Sahle FF; Gebre-Mariam T; Asres K; Neubert RH
    Eur J Pharm Biopharm; 2012 Jan; 80(1):61-6. PubMed ID: 21924356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin.
    Minghetti P; Casiraghi A; Cilurzo F; Montanari L
    Boll Chim Farm; 2001; 140(2):63-7. PubMed ID: 11417388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The kinetics of in vitro release of nitroglycerin from various percutaneous administration systems].
    Pirotte B; Jaminet F
    J Pharm Belg; 1984; 39(3):125-35. PubMed ID: 6434726
    [No Abstract]   [Full Text] [Related]  

  • 6. [The dynamics of the drug release from ointment bases. Part 3: The effects of some emulsifiers on the liberation of nitroglycerin (author's transl)].
    Pasich J; Borgieł B; Pałka J
    Pharmazie; 1981; 36(2):112-3. PubMed ID: 6785768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release of betamethasone dipropionate from petrolatum-based ointments.
    Zatz JL; Varsano J; Shah VP
    Pharm Dev Technol; 1996 Oct; 1(3):293-8. PubMed ID: 9552312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an in vitro release method for topical particulate delivery systems.
    Lusina Kregar M; Dürrigl M; Rožman A; Jelčić Ž; Cetina-Čižmek B; Filipović-Grčić J
    Int J Pharm; 2015 May; 485(1-2):202-14. PubMed ID: 25772416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug release from semisolid dosage forms: a comparison of two testing methods.
    Petró É; Paál TL; Erős I; Kenneth AS; Baki G; Csóka I
    Pharm Dev Technol; 2015 May; 20(3):330-6. PubMed ID: 24328512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical delivery of caffeine from some commercial formulations.
    Dias M; Farinha A; Faustino E; Hadgraft J; Pais J; Toscano C
    Int J Pharm; 1999 May; 182(1):41-7. PubMed ID: 10332073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of drug release from ointments: Role of transient-boundary layer.
    Xu X; Al-Ghabeish M; Krishnaiah YS; Rahman Z; Khan MA
    Int J Pharm; 2015 Oct; 494(1):31-9. PubMed ID: 26241753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical release from topical formulations across synthetic membranes: infinite dose.
    Parks JM; Cleek RL; Bunge AL
    J Pharm Sci; 1997 Feb; 86(2):187-92. PubMed ID: 9040093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct estimation of the permeation of topical excipients through artificial membranes and human skin with non-invasive Terahertz time-domain techniques.
    Lopez-Dominguez V; Boix-Montañes A; Redo-Sanchez A; Tejada-Palacios J
    J Pharm Pharmacol; 2016 Jul; 68(7):873-82. PubMed ID: 27138975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro release of hydrocortisone from topical preparations and automated procedure.
    Shah VP; Elkins J; Hanus J; Noorizadeh C; Skelly JP
    Pharm Res; 1991 Jan; 8(1):55-9. PubMed ID: 2014209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
    Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
    Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equipment and method for in vitro release measurements on topical dosage forms.
    Sesto Cabral ME; Ramos AN; Cabrera CA; Valdez JC; González SN
    Pharm Dev Technol; 2015; 20(5):619-25. PubMed ID: 25318476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite poly(2-hydroxyethyl methacrylate) membranes as rate-controlling barriers for transdermal applications.
    Sun YM; Huang JJ; Lin FC; Lai JY
    Biomaterials; 1997 Apr; 18(7):527-33. PubMed ID: 9105591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical nitroglycerin ointment as an aid to insertion of peripheral venous catheters in neonates.
    Maynard EC; Oh W
    J Pediatr; 1989 Mar; 114(3):474-6. PubMed ID: 2493523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.